Similar articles

• Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.

  Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Léobon B, Robidel E, Borsani P, Le Lorc'h M, Bissery A, Chomienne C, Bruneval P, Marolleau JP, Vilquin JT, Hagège A, Samuel JL, Menasché P. Agbulut O, et al. J Am Coll Cardiol. 2004 Jul 21;44(2):458-63. doi: 10.1016/j.jacc.2004.03.083. J Am Coll Cardiol. 2004. PMID: 15261948
• Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.

  Bonaros N, Rauf R, Werner E, Schlechta B, Rohde E, Kocher A, Bonatti J, Laufer G. Bonaros N, et al. Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):249-55. doi: 10.1510/icvts.2007.162917. Epub 2007 Oct 9. Interact Cardiovasc Thorac Surg. 2008. PMID: 17925321
• [Expression of AC133 vs. CD34 in acute childhood leukemias].

  Ebener U, Brinkmann A, Zotova V, Niegemann E, Wehner S. Ebener U, et al. Klin Padiatr. 2000 May-Jun;212(3):90-8. doi: 10.1055/s-2000-9659. Klin Padiatr. 2000. PMID: 10916777 German.
• [Cardiac cell therapy: the puzzle is waiting to be solved].

  Canepa M, Coviello D, Chiarella F. Canepa M, et al. G Ital Cardiol (Rome). 2006 Apr;7(4):252-65. G Ital Cardiol (Rome). 2006. PMID: 16700408 Review. Italian.
• Cell transplantation for myocardial regeneration: hype or reality?

  Björquist P, Jeppsson A. Björquist P, et al. Scand Cardiovasc J. 2004 Oct;38(5):259-64. doi: 10.1080/14017430410016350. Scand Cardiovasc J. 2004. PMID: 15513307 Review. No abstract available.